Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

May 20, 2019

Cellectar Biosciences Announces Closing of $10.0 Million Financing

May 16, 2019

Cellectar Biosciences Announces $10.0 Million Financing

May 15, 2019

CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma

May 13, 2019

Cellectar Receives FDA Fast Track Designation for CLR 131 in Relapsed or Refractory Multiple Myeloma